| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 35,0 k € | +28.5% | 27,3 k € | -34.7% | 41,8 k € | -5.3% | 44,1 k € | -13.4% | 50,9 k € | -1.1% | 51,4 k € | +47.1% | 35,0 k € | -66.2% | 103,5 k € | -43.9% | 184,5 k € | +24.8% | 147,8 k € | +14.0% | 129,7 k € | -3.8% | 134,8 k € | +0.2% | 134,5 k € | +52.3% | 88,3 k € | +87.0% | 47,2 k € | -48.7% | 92,0 k € | +188.0% | 31,9 k € | +215.9% | -27,6 k € | |
| EBITDA | 24,0 k € | +17.0% | 20,5 k € | -43.0% | 35,9 k € | -4.8% | 37,7 k € | -17.4% | 45,6 k € | -4.9% | 48,0 k € | +65.1% | 29,1 k € | -69.2% | 94,4 k € | -46.0% | 174,9 k € | +29.1% | 135,4 k € | +13.7% | 119,1 k € | -5.9% | 126,6 k € | +1.5% | 124,7 k € | +56.2% | 79,8 k € | +128.1% | 35,0 k € | -58.6% | 84,5 k € | +200.0% | 28,2 k € | +190.1% | -31,2 k € | |
| Operating profit | -10,1 k € | +27.1% | -13,8 k € | -911.4% | 1,7 k € | -50.6% | 3,4 k € | +878.2% | -443,1 € | -118.0% | 2,5 k € | +113.6% | -18,1 k € | -138.9% | 46,5 k € | -54.7% | 102,8 k € | +58.3% | 64,9 k € | +35.8% | 47,8 k € | +36.2% | 35,1 k € | +7.7% | 32,6 k € | +373.5% | -11,9 k € | +73.6% | -45,2 k € | -1151.4% | 4,3 k € | +113.8% | -31,2 k € | +67.0% | -94,7 k € | |
| Profit/loss | -1,8 k € | +81.2% | -9,7 k € | -283.4% | 5,3 k € | -27.2% | 7,3 k € | +450.7% | 1,3 k € | -47.6% | 2,5 k € | +115.9% | -15,9 k € | -133.9% | 46,9 k € | -44.0% | 83,8 k € | +14.0% | 73,5 k € | +139.9% | 30,6 k € | +73.4% | 17,7 k € | +26.6% | 14,0 k € | +131.1% | -44,9 k € | -195.7% | -15,2 k € | +52.1% | -31,7 k € | +49.8% | -63,2 k € | +51.5% | -130,2 k € | |
| Equity | 974,7 k € | -0.2% | 976,5 k € | -1.0% | 986,2 k € | +0.5% | 980,9 k € | +0.7% | 973,6 k € | +0.1% | 972,3 k € | +0.3% | 969,8 k € | -13.7% | 1,1 M € | +4.4% | 1,1 M € | +8.4% | 992,9 k € | +8.0% | 919,4 k € | +3.4% | 888,8 k € | +2.0% | 871,1 k € | +1.6% | 857,1 k € | -5.0% | 902,1 k € | -1.7% | 917,3 k € | -3.3% | 949,0 k € | -6.2% | 1,0 M € | |
| Total assets | 977,2 k € | -0.6% | 983,1 k € | -1.0% | 993,0 k € | +0.6% | 987,5 k € | +0.7% | 980,4 k € | -0.1% | 981,1 k € | +0.1% | 980,6 k € | -13.5% | 1,1 M € | -22.6% | 1,5 M € | -10.8% | 1,6 M € | +0.4% | 1,6 M € | -0.9% | 1,6 M € | -8.3% | 1,8 M € | -2.0% | 1,8 M € | +0.3% | 1,8 M € | -20.6% | 2,3 M € | -0.1% | 2,3 M € | -3.2% | 2,4 M € | |
| Cash | 83,6 k € | +102.2% | 41,3 k € | -17.3% | 50,0 k € | -41.4% | 85,2 k € | -37.3% | 135,9 k € | -20.7% | 171,4 k € | +33.3% | 128,6 k € | +21.0% | 106,3 k € | +274.6% | 28,4 k € | -85.3% | 193,3 k € | +88.8% | 102,4 k € | +66.1% | 61,6 k € | -45.5% | 113,1 k € | +81.0% | 62,5 k € | +40.8% | 44,4 k € | -39.9% | 73,9 k € | -26.1% | 100,0 k € | +19.4% | 83,7 k € | |
| Debts | 2,6 k € | -60.6% | 6,6 k € | -3.2% | 6,8 k € | +3.6% | 6,6 k € | -3.5% | 6,8 k € | -23.1% | 8,8 k € | -4.6% | 9,3 k € | -5.0% | 9,8 k € | -97.5% | 387,6 k € | -39.9% | 645,4 k € | -9.4% | 712,5 k € | -5.9% | 757,3 k € | -18.1% | 924,9 k € | -4.8% | 971,9 k € | +4.8% | 927,8 k € | -33.1% | 1,4 M € | +2.1% | 1,4 M € | +0.1% | 1,4 M € | |
Public limited company · Woluwe-Saint-Lambert · incorporated on 13/12/1995
Public limited company loss-making in the latest fiscal year. Cash position rising (+102.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
PHARMAHOLD LB is a Public limited company incorporated in 1995. Its main activity is: Accounting, bookkeeping and auditing activities; tax consultancy. Its registered office is in Woluwe-Saint-Lambert.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette